Ads

 

Ads

 

Ads

 

Top Pharmaceutical Companies in S&P 500 List by Market Cap as on July-30-2023

Top Pharmaceutical Companies in S&P 500 List by Market Cap as on July-30-2023. Biggest and Top Pharmaceutical Companies in S&P 500 Companies by Market Cap. Largest Top Pharmaceutical Companies in S&P 500 List by Market Cap as on July-30-2023.
Metatag Title
Top Pharmaceutical Companies in S&P 500
Metatag Abstract
Top Pharmaceutical Companies in S&P 500, Biggest Pharmaceutical Companies in S&P 500, Largest Pharmaceutical Companies in S&P 500.
  1. Cardinal Health

    World Rank (Jan-05-2024)
    709
    Market Cap (Jan-05-2024)
    26.017 Billion USD
    World Rank (Jul-30-2023)
    807
    Market Cap (Jul-30-2023)
    23.344 Billion USD
    World Rank (Dec-25-2022)
    791
    Market Cap (Dec-25-2022)
    20.984 Billion USD
    World Rank (Jan-07-2022)
    1,321
    Market Cap (Jan-07-2022)
    15.28 Billion USD
    Annual Revenue in USD
    205,012 Million USD
    Annual Operating Income in USD
    1,770 Million USD
    Annual Net Income in USD
    261 Million USD
    Annual Results for Period Ending
    Jun-2023 ending period
    Headquarters Country
    Stock Category
    Company Profile

    Cardinal Health, Inc. (NYSE: CAH) is a global, integrated healthcare services and products company, providing customized solutions for hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. Headquarters is in USA.

    As on 2022, Cardinal Health, Inc. has 46,500 employees.

    Cardinal Health, Inc. annual revenue generated for period ending Jun-2022 was 181,364 million USD.

  2. STERIS plc

    World Rank (Jan-05-2024)
    855
    Market Cap (Jan-05-2024)
    21.341 Billion USD
    World Rank (Jul-30-2023)
    826
    Market Cap (Jul-30-2023)
    22.694 Billion USD
    World Rank (Dec-25-2022)
    914
    Market Cap (Dec-25-2022)
    18.174 Billion USD
    World Rank (Jan-07-2022)
    891
    Market Cap (Jan-07-2022)
    23.49 Billion USD
    Annual Revenue in USD
    4,957 Million USD
    Annual Operating Income in USD
    759 Million USD
    Annual Net Income in USD
    107 Million USD
    Annual Results for Period Ending
    Mar-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    STERIS is a leading provider of infection prevention and other procedural products and services. The company is focused primarily on healthcare, pharmaceutical and medical device Customers. Headquarters is in Dublin, Ireland.

  3. Incyte Corporation

    World Rank (Jan-05-2024)
    1,185
    Market Cap (Jan-05-2024)
    14.923 Billion USD
    World Rank (Jul-30-2023)
    1,265
    Market Cap (Jul-30-2023)
    14.075 Billion USD
    World Rank (Dec-25-2022)
    918
    Market Cap (Dec-25-2022)
    18.101 Billion USD
    World Rank (Jan-07-2022)
    1,253
    Market Cap (Jan-07-2022)
    16.17 Billion USD
    Annual Revenue in USD
    3,394 Million USD
    Annual Operating Income in USD
    591 Million USD
    Annual Net Income in USD
    340 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Incyte Corporation is a Bio-Pharmaceutical company with headquarters is in Delaware, USA.

    As on 2021, Incyte Corporation has 2,094 employees, 989 are in research and development, 187 in medical affairs, 638 in sales and marketing and 280 in operations support, finance and administrative positions.

    As on 2022, Incyte Corporation has 2,324 employees.

    Incyte Corporation annual revenue generated for period ending Dec-2022 was 3,394 million USD.

  4. Perrigo Company

    World Rank (Jan-05-2024)
    3,172
    Market Cap (Jan-05-2024)
    4.552 Billion USD
    World Rank (Jul-30-2023)
    3,003
    Market Cap (Jul-30-2023)
    4.946 Billion USD
    World Rank (Dec-25-2022)
    3,011
    Market Cap (Dec-25-2022)
    4.446 Billion USD
    World Rank (Jan-07-2022)
    3,057
    Market Cap (Jan-07-2022)
    5.45 Billion USD
    Annual Revenue in USD
    4,451 Million USD
    Annual Operating Income in USD
    121 Million USD
    Annual Net Income in USD
    -140 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile
    Perrigo is a leading global healthcare company, focused on providing value to its customers and consumers by delivering Quality Affordable Healthcare Products. Perrigo has built a unique business model that is best described as the convergence of a fast-moving consumer goods company, a high-quality pharmaceutical manufacturing organization and a world-class supply chain network. Perrigo is the world's largest manufacturer of OTC healthcare products and supplier of infant formulas for the store brand market.

Share

Ads